CELEBRA

Celebra Adverse Events Reported to the FDA Over Time

How are Celebra adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Celebra, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Celebra is flagged as the suspect drug causing the adverse event.

Most Common Celebra Adverse Events Reported to the FDA

What are the most common Celebra adverse events reported to the FDA?

Drug Ineffective	31 (2.42%)
Hypersensitivity	28 (2.19%)
Dyspnoea	23 (1.8%)
Abdominal Pain Upper	19 (1.48%)
Arthralgia	19 (1.48%)
Nausea	17 (1.33%)
Vomiting	16 (1.25%)
Fall	14 (1.09%)
Pain	14 (1.09%)
Pain In Extremity	14 (1.09%)
Abdominal Pain	13 (1.02%)
	Show More
Dizziness	13 (1.02%)
Erythema	12 (.94%)
Amnesia	11 (.86%)
Asthenia	11 (.86%)
Blood Pressure Increased	11 (.86%)
Malaise	11 (.86%)
Chest Pain	10 (.78%)
Headache	10 (.78%)
Myocardial Infarction	10 (.78%)
Pruritus	10 (.78%)
Swelling Face	10 (.78%)
Tachycardia	10 (.78%)
Tremor	10 (.78%)
Vision Blurred	9 (.7%)
Weight Decreased	9 (.7%)
Feeling Abnormal	8 (.63%)
Renal Pain	8 (.63%)
Somnolence	8 (.63%)
Swelling	8 (.63%)
Anaemia	7 (.55%)
Arrhythmia	7 (.55%)
Blood Pressure Decreased	7 (.55%)
Dehydration	7 (.55%)
Diplopia	7 (.55%)
Fatigue	7 (.55%)
Formication	7 (.55%)
Hypertension	7 (.55%)
Hypoaesthesia	7 (.55%)
Labyrinthitis	7 (.55%)
Oedema Mouth	7 (.55%)
Throat Tightness	7 (.55%)
Blindness	6 (.47%)
Blood Cholesterol Increased	6 (.47%)
Cardiac Disorder	6 (.47%)
Death	6 (.47%)
Drug Hypersensitivity	6 (.47%)
Eye Swelling	6 (.47%)
Feeling Hot	6 (.47%)
Haematemesis	6 (.47%)
Haemorrhage	6 (.47%)
Hypotension	6 (.47%)
Limb Injury	6 (.47%)
Memory Impairment	6 (.47%)
Paraesthesia	6 (.47%)
Purulence	6 (.47%)
Rash Macular	6 (.47%)
Renal Failure	6 (.47%)
Skin Exfoliation	6 (.47%)
Spinal Disorder	6 (.47%)
Stevens-johnson Syndrome	6 (.47%)
Arthropathy	5 (.39%)
Asthma	5 (.39%)
Cardiac Arrest	5 (.39%)
Cerebral Infarction	5 (.39%)
Cerebrovascular Accident	5 (.39%)
Cold Sweat	5 (.39%)
Constipation	5 (.39%)
Crying	5 (.39%)
Face Oedema	5 (.39%)
Hyperhidrosis	5 (.39%)
Insomnia	5 (.39%)
Oedema Peripheral	5 (.39%)
Pruritus Generalised	5 (.39%)
Sensory Disturbance	5 (.39%)
Suffocation Feeling	5 (.39%)
Syncope	5 (.39%)
Abasia	4 (.31%)
Abdominal Distension	4 (.31%)
Acute Myocardial Infarction	4 (.31%)
Anaphylactic Shock	4 (.31%)
Anorexia	4 (.31%)
Blister	4 (.31%)
Blood Glucose Decreased	4 (.31%)
Burning Sensation	4 (.31%)
Bursitis	4 (.31%)
Cardiac Failure	4 (.31%)
Convulsion	4 (.31%)
Cough	4 (.31%)
Diarrhoea	4 (.31%)
Drug Ineffective For Unapproved Ind...	4 (.31%)
Drug Interaction	4 (.31%)
Dysarthria	4 (.31%)
Dysentery	4 (.31%)
Ear Injury	4 (.31%)
Flatulence	4 (.31%)
Gait Disturbance	4 (.31%)
Gastrointestinal Disorder	4 (.31%)
Hyponatraemia	4 (.31%)
Hypophosphataemia	4 (.31%)
Laziness	4 (.31%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Celebra, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Celebra is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Celebra

What are the most common Celebra adverse events reported to the FDA?

Neurological	82 (6.41%)
Epidermal And Dermal Conditions	81 (6.33%)
Gastrointestinal Signs	77 (6.02%)
Respiratory	52 (4.06%)
Therapeutic And Nontherapeutic Effe...	40 (3.13%)
Allergic Conditions	38 (2.97%)
Injuries	37 (2.89%)
Vision	34 (2.66%)
Infections - Pathogen Unspecified	31 (2.42%)
Cardiac Arrhythmias	30 (2.34%)
Joint	27 (2.11%)
	Show More
Cardiac And Vascular Investigations	26 (2.03%)
Central Nervous System Vascular	23 (1.8%)
Coronary Artery	23 (1.8%)
Mental Impairment	22 (1.72%)
Movement Disorders	19 (1.48%)
Musculoskeletal And Connective Tiss...	19 (1.48%)
Urinary Tract Signs	19 (1.48%)
Oral Soft Tissue Conditions	17 (1.33%)
Bone And Joint Injuries	15 (1.17%)
Renal Disorders	15 (1.17%)
Physical Examination Topics	14 (1.09%)
Gastrointestinal Hemorrhages	13 (1.02%)
Gastrointestinal Motility And Defec...	13 (1.02%)
Bone Disorders	12 (.94%)
Cardiac Disorder Signs	12 (.94%)
Electrolyte And Fluid Balance Condi...	12 (.94%)
Eye	12 (.94%)
Gastrointestinal Ulceration And Per...	12 (.94%)
Headaches	12 (.94%)
Hepatic And Hepatobiliary	12 (.94%)
Skin Appendage Conditions	12 (.94%)
Bronchial Disorders	11 (.86%)
Tongue Conditions	10 (.78%)
Decreased And Nonspecific Blood Pre...	9 (.7%)
Vascular Hypertensive	9 (.7%)
Vascular Hemorrhagic	8 (.63%)
Anemias Nonhemolytic And Marrow Dep...	7 (.55%)
Deliria	7 (.55%)
Fatal Outcomes	7 (.55%)
Lipid Analyses	7 (.55%)
Muscle	7 (.55%)
Appetite And General Nutritional	6 (.47%)
Embolism And Thrombosis	6 (.47%)
Gastrointestinal Conditions	6 (.47%)
Mood Disorders	6 (.47%)
Sleep Disorders	6 (.47%)
Viral Infectious	6 (.47%)
Heart Failures	5 (.39%)
Tendon, Ligament And Cartilage	5 (.39%)
Upper Respiratory Tract Disorders	5 (.39%)
Vulvovaginal Disorders	5 (.39%)
Angiedema And Urticaria	4 (.31%)
Anxiety Disorders	4 (.31%)
Arteriosclerosis, Stenosis, Vascula...	4 (.31%)
Bone, Calcium, Magnesium And Phosph...	4 (.31%)
Breast	4 (.31%)
Disturbances In Thinking	4 (.31%)
Gastrointestinal Inflammatory Condi...	4 (.31%)
Metabolic, Nutritional And Blood Ga...	4 (.31%)
Seizures	4 (.31%)
Synovial And Bursal	4 (.31%)
Aural	3 (.23%)
Cardiac Valve	3 (.23%)
Chemical Injury And Poisoning	3 (.23%)
Depressed Mood Disorders	3 (.23%)
Endocrine Neoplasms Malignant And U...	3 (.23%)
Glucose Metabolism Disorders	3 (.23%)
Hepatobiliary	3 (.23%)
Lifestyle Issues	3 (.23%)
Medication Errors	3 (.23%)
Menstrual Cycle And Uterine Bleedin...	3 (.23%)
Ocular Infections, Irritations And ...	3 (.23%)
Ocular Neuromuscular	3 (.23%)
Penile And Scrotal Disorders	3 (.23%)
Peripheral Neuropathies	3 (.23%)
Pulmonary Vascular	3 (.23%)
Renal And Urinary Tract Neoplasms B...	3 (.23%)
Salivary Gland Conditions	3 (.23%)
Skin And Subcutaneous Tissue	3 (.23%)
Venous Varices	3 (.23%)
Bacterial Infectious	2 (.16%)
Bone And Joint Therapeutic Procedur...	2 (.16%)
Coagulopathies And Bleeding Diathes...	2 (.16%)
Cognitive And Attention Disorders	2 (.16%)
Exocrine Pancreas Conditions	2 (.16%)
External Ear Disorders	2 (.16%)
Gastrointestinal Stenosis And Obstr...	2 (.16%)
Hematology Investigations	2 (.16%)
Hepatobiliary Therapeutic Procedure...	2 (.16%)
Injuries By Physical Agents	2 (.16%)
Inner Ear And Viiith Cranial Nerve	2 (.16%)
Musculoskeletal And Connective Tiss...	2 (.16%)
Myocardial	2 (.16%)
Procedural And Device Related Injur...	2 (.16%)
Prostatic Disorders	2 (.16%)
Psychiatric And Behavioural Symptom...	2 (.16%)
Schizophrenia And Other Psychotic	2 (.16%)
Skin Vascular Abnormalities	2 (.16%)
Vascular	2 (.16%)
Abortions And Stillbirth	1 (.08%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Celebra, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Celebra is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.